China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid

This post was originally published on this site

https://content.fortune.com/wp-content/uploads/2022/07/GettyImages-1292997730-e1658804672814.jpg



China approves first domestic anti-COVID pill, Azvudine, as it battles new Omicron outbreaks | Fortune